Cindy Berejikian
Chief Operating Officer at MINERALYS THERAPEUTICS, INC.
Profile
Cindy Berejikian is currently the Executive Vice President-Operations at Mineralys Therapeutics, Inc. She previously worked as the Director & Global Program Manager at Amgen, Inc. and as the Vice President-Program Management at Otonomy, Inc. Ms. Berejikian holds an MBA degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Santa Barbara.
Cindy Berejikian active positions
| Companies | Position | Start |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Chief Operating Officer | - |
Former positions of Cindy Berejikian
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Director/Board Member | - |
| OTONOMY | Corporate Officer/Principal | - |
Training of Cindy Berejikian
| University of California, Los Angeles | Masters Business Admin |
| University of California, Santa Barbara | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Cindy Berejikian
